百奥泰 (688177)
Bio-Thera Solutions, Ltd.
K-Line Chart
No K-line data available
Company NameBio-Thera Solutions Ltd.
Listing Date2020-02-21
Issue Price32.76RMB
Registered Capital4140810k RMB
Legal RepresentativeShengfeng Li
Registered AddressNo. 18, Helix 2nd Road, Guangzhou International Bio-Island, Huangpu District, Guangzhou
IndustryBiological Products
Main BusinessResearch, development, and production of innovative drugs and biosimilars
Company ProfileBio-Thera Solutions Ltd. is a biopharmaceutical company founded by overseas returnee elites, dedicated to the research and development of next-generation antibody innovative drugs and biosimilars for the treatment of cancer, autoimmune diseases, cardiovascular diseases, and other life-threatening major diseases. As a leader in next-generation antibody drug development, Bio-Thera has successfully established a leading antibody drug technology platform and built a rich pipeline of innovative drugs and biosimilar products. There are 25 products in the pipeline, with 8 candidate products at different clinical stages. The adalimumab biosimilar (the original drug being the global 'blockbuster drug') for autoimmune diseases is expected to be the first biosimilar in China among similar products; Batifiban for cardiovascular diseases is China's first Class 1.1 new drug targeting the β3 integrin receptor. The anti-HER2 ADC injection for breast cancer, the bevacizumab biosimilar for various solid tumors, and the tocilizumab biosimilar for autoimmune diseases have entered Phase III clinical trials.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor....
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | ChinaAMC | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund | Public Fund | 2,000 | 4.1 |
| 6 | HTFF | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities | Broker | 1,500 | 3.1 |
| 8 | Guotai Junan | Broker | 1,200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information